Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation
Dhanunjaya Lakkireddy(Texas Cardiac Arrhythmia), Andrea Natale(St David's Medical Center), Luigi Di Biase(Albert Einstein College of Medicine), Rhea Pimentel(The University of Kansas Health System), André d’Ávila, Prasant Mohanty(Texas Cardiac Arrhythmia), Vijay Swarup(Arizona Heart Hospital), James O. Coffey(Mount Sinai Medical Center), Pasquale Santangeli(Texas Cardiac Arrhythmia), Moussa Mansour(Massachusetts General Hospital), Vivek Y. Reddy(GE Global Research (United States)), J. David Burkhardt(Texas Cardiac Arrhythmia), Javier Sánchez(Texas Cardiac Arrhythmia), Fadi Chalhoub(Massachusetts General Hospital), Naushad Shaik, Subba Reddy Vanga(The University of Kansas Health System), Jeremy N. Ruskin(Massachusetts General Hospital), Yeruva Madhu Reddy(The University of Kansas Health System), George Monir(AdventHealth Orlando)
Cited by 357
Related Papers
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|EP Europace|2017|1.2k
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device
|Circulation|2016|855
Does the Left Atrial Appendage Morphology Correlate With the Risk of Stroke in Patients With Atrial Fibrillation?
|Journal of the American College of Cardiology|2012|834
Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure
|New England Journal of Medicine|2008|763